Many patients who qualify for monoclonal antibodies say their doctors never mentioned them, even though it has been nearly a year since antibodies were first authorized by the FDA.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
